MedPath

Prognostic value of Fluorine-18 3- deoxy-3-fluorothymidine ([18F]FLT) uptake in resectable liver metastases of colorectal cancer

Completed
Conditions
bowel cancer
colorectalcancer
10019815
Registration Number
NL-OMON36536
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

*technically resectable liver metastases at the time of hepatic recurrence diagnosis
*written informed consent

Exclusion Criteria

*claustrophobia prohibiting PET-scanning
*systemic cancer therapy within 3 months prior to PET
*largest liver metastasis <2 cm

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>prognostic accuracy of [18F]FLT uptake in liver metastases with respect to<br /><br>patient outcomes (DFS), </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>prognostic accuracy of [18F]FLT uptake vs. existing prognostic indices with<br /><br>respect to patient outcomes (DFS). </p><br>
© Copyright 2025. All Rights Reserved by MedPath